keyword
https://read.qxmd.com/read/38554241/skin-color-reporting-in-squamous-cell-carcinoma-related-randomized-controlled-trials-in-top-dermatology-journals-a-systematic-review
#1
REVIEW
Natasha L Salmen, Klarens Menage, Anthony N Baumann, Deven P Curtis, Robert T Brodell
The objectives are to determine the frequency that skin color is reported in randomized controlled trials (RCTs) involving squamous cell carcinoma (SCC) detection and treatment in leading dermatology journals. A systematic review of RCTs involving SCC was conducted among the top ten most impactful dermatology journals from inception to July 10th, 2023. Studies were included if they reviewed the treatment, prevention, or detection of SCC, involved patients directly and were classified as traditional RCTs. Studies were considered positive for reporting SOC if there was any demographic data in the methods or results of the following terms: Fitzpatrick scale, race, ethnicity, sunburn tendency, or skin of color...
March 30, 2024: Archives of Dermatological Research
https://read.qxmd.com/read/38184691/management-of-non-metastatic-anal-cancer-in-the-elderly-ancillary-study-of-the-french-multicenter-prospective-cohort-ffcd-anabase
#2
JOURNAL ARTICLE
Claire Gouriou, Claire Lemanski, Pascal Pommier, Karine Le Malicot, Angélique Saint, Eleonor Rivin Del Campo, Cécile Evin, Laurent Quero, Pauline Regnault, Nabil Baba-Hamed, Philippe Ronchin, Gilles Crehange, David Tougeron, Elodie Menager-Tabourel, Olivia Diaz, Michael Hummelsberger, Anne de la Rocherfordiere, Franck Drouet, Véronique Vendrely, Astrid Lièvre
BACKGROUND: Standard care for non-metastatic squamous cell carcinoma of the anus (SCCA) is chemoradiotherapy, data about elderly patients are scarce. METHODS: All consecutive patients treated for non-metastatic SCCA from the French multicenter FFCD-ANABASE cohort were included. Two groups were defined according to age: elderly (≥75 years) and non-elderly (<75). RESULTS: Of 1015 patients, 202 (19.9%) were included in the elderly group; median follow-up was 35...
January 6, 2024: British Journal of Cancer
https://read.qxmd.com/read/37087902/outcomes-of-extended-resection-for-locally-advanced-thymic-malignancies
#3
JOURNAL ARTICLE
Jean Baptiste Menager, Olaf Mercier, Antonin Levy, Angela Botticella, Pauline Pradère, Dominique Fabre, Justin Issard, Charles Naltet, David Planchard, Fabrice Barles, Vincent De Montpreville, Cécile Le Pechoux, Benjamin Besse, Elie Fadel
BACKGROUND: Thymic malignancies are rare tumors about which data are limited. Our objective here was to evaluate the outcomes and risk factors for complications and death in patients who underwent extended surgery to remove thymic malignancies. METHODS: We retrospectively included patients who underwent extended resection of locally advanced, nonmetastatic thymic malignancies at our institution. Patients were deemed eligible for resection by a multidisciplinary team...
March 23, 2023: Respiratory medicine and research
https://read.qxmd.com/read/36813175/treatment-outcome-and-prognostic-factors-in-non-metastatic-anal-cancer-the-french-nationwide-cohort-study-ffcd-anabase
#4
JOURNAL ARTICLE
Véronique Vendrely, Claire Lemanski, Pascal Pommier, Karine LE Malicot, Angélique Saint, Eleonor Rivin Del Campo, Pauline Regnault, Nabil Baba-Hamed, Philippe Ronchin, Gilles Crehange, David Tougeron, Elodie Menager-Tabourel, Olivia Diaz, Michael Hummelsberger, Mathieu Minsat, Franck Drouet, Anne Larrouy, Didier Peiffert, Astrid Lievre, Xavier Zasadny, Vincent Hautefeuille, Françoise Mornex, Côme Lepage, Laurent Quero
INTRODUCTION: International guidelines regarding the treatment of squamous cell carcinoma of the anus (SCCA) recommend intensity-modulated radiotherapy (IMRT) combined with mitomycin-based chemotherapy (CT). The French FFCD-ANABASE cohort aimed at evaluating clinical practices, treatment, and outcomes of SCCA patients. METHODS: This prospective multicentric observational cohort included all non-metastatic SCCA patients treated in 60 French centers from January 2015 to April 2020...
February 20, 2023: Radiotherapy and Oncology
https://read.qxmd.com/read/36755030/the-role-of-tumor-model-in-magnetic-targeting-of-magnetosomes-and-ultramagnetic-liposomes
#5
JOURNAL ARTICLE
Alberto Curcio, Jose Efrain Perez, Sandra Prévéral, Alexandre Fromain, Coralie Genevois, Aude Michel, Aurore Van de Walle, Yoann Lalatonne, Damien Faivre, Christine Ménager, Claire Wilhelm
The combined passive and active targeting of tumoral tissue remains an active and relevant cancer research field. Here, we exploit the properties of two highly magnetic nanomaterials, magnetosomes and ultramagnetic liposomes, in order to magnetically target prostate adenocarcinoma tumors, implanted orthotopically or subcutaneously, to take into account the role of tumor vascularization in the targeting efficiency. Analysis of organ biodistribution in vivo revealed that, for all conditions, both nanomaterials accumulate mostly in the liver and spleen, with an overall low tumor retention...
February 8, 2023: Scientific Reports
https://read.qxmd.com/read/36157422/long-term-outcomes-after-chest-wall-resection-and-repair-with-titanium-bars-and-sternal-plates
#6
JOURNAL ARTICLE
Hugo Clermidy, Guillaume Fadel, Alexandra De Lemos, Pauline Pradere, Delphine Mitilian, Antoine Girault, Jean-Baptiste Menager, Dominique Fabre, Sacha Mussot, Nicolas Leymarie, Elie Fadel, Olaf Mercier
Objectives: En-bloc complete resection remains the treatment of choice for localized chest wall (CW) tumors. Titanium bars reconstruction demonstrated encouraging results with satisfactory early outcomes. However, long-term outcomes remain under-reported. The purpose of this study is to evaluate long-term outcomes after CW resection and repair with titanium devices. Methods: From June 2012 to December 2018, we retrospectively reviewed all patients with CW tumors who underwent surgical resection and repair using titanium...
2022: Frontiers in Surgery
https://read.qxmd.com/read/35880776/the-economic-burden-of-disease-in-france-from-the-national-health-insurance-perspective-the-healthcare-expenditures-and-conditions-mapping-used-to-prepare-the-french-social-security-funding-act-and-the-public-health-act
#7
JOURNAL ARTICLE
Antoine Rachas, Christelle Gastaldi-Ménager, Pierre Denis, Pauline Barthélémy, Panayotis Constantinou, Jérôme Drouin, Dimitri Lastier, Thomas Lesuffleur, Corinne Mette, Muriel Nicolas, Laurence Pestel, Sébastien Rivière, Ayden Tajahmady, Claude Gissot, Anne Fagot-Campagna
BACKGROUND: Identifying the most frequently treated and the costliest health conditions is essential for prioritizing actions to improve the resilience of health systems. OBJECTIVES: Healthcare Expenditures and Conditions Mapping describes the annual economic burden of 58 health conditions to prepare the French Social Security Funding Act and the Public Health Act. DESIGN: Annual cross-sectional study (2015-2019) based on the French national health database...
July 26, 2022: Medical Care
https://read.qxmd.com/read/35799352/hariboss-a-curated-database-of-rna-small-molecules-structures-to-aid-rational-drug-design
#8
JOURNAL ARTICLE
F P Panei, R Torchet, H Menager, P Gkeka, M Bonomi
MOTIVATION: RNA molecules are implicated in numerous fundamental biological processes and many human pathologies, such as cancer, neurodegenerative disorders, muscular diseases, and bacterial infections. Modulating the mode of action of disease-implicated RNA molecules can lead to the discovery of new therapeutical agents and even address pathologies linked to 'undruggable' protein targets. This modulation can be achieved by direct targeting of RNA with small molecules. As of today, only a few RNA-targeting small molecules are used clinically...
July 7, 2022: Bioinformatics
https://read.qxmd.com/read/35639792/high-dose-versus-standard-dose-vitamin-d-supplementation-in-older-adults-with-covid-19-covit-trial-a-multicenter-open-label-randomized-controlled-superiority-trial
#9
RANDOMIZED CONTROLLED TRIAL
Cédric Annweiler, Mélinda Beaudenon, Jennifer Gautier, Justine Gonsard, Sophie Boucher, Guillaume Chapelet, Astrid Darsonval, Bertrand Fougère, Olivier Guérin, Marjorie Houvet, Pierre Ménager, Claire Roubaud-Baudron, Achille Tchalla, Jean-Claude Souberbielle, Jérémie Riou, Elsa Parot-Schinkel, Thomas Célarier
BACKGROUND: Vitamin D supplementation has been proposed as a treatment for Coronavirus Disease 2019 (COVID-19) based on experimental data and data from small and uncontrolled observational studies. The COvid19 and VITamin d TRIAL (COVIT-TRIAL) study was conducted to test whether a single oral high dose of cholecalciferol (vitamin D3) administered within 72 hours after the diagnosis of COVID-19 improves, compared to standard-dose cholecalciferol, the 14-day overall survival among at-risk older adults infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)...
May 2022: PLoS Medicine
https://read.qxmd.com/read/35439806/biotinylated-magnetic-molecularly-imprinted-polymer-nanoparticles-for-cancer-cell-targeting-and-controlled-drug-delivery
#10
JOURNAL ARTICLE
Maria Nerantzaki, Aude Michel, Laurence Petit, Maylis Garnier, Christine Ménager, Nébéwia Griffete
Here, multivalent functions have been successfully integrated on a single core-shell type nanostructure, for remote-controlled and receptor-targeted intracellular delivery of doxorubicin (DOX) to breast cancer cells that overexpress biotin receptors.
May 5, 2022: Chemical Communications: Chem Comm
https://read.qxmd.com/read/35436335/a-m%C3%A3-nage-%C3%A3-trois-of-cytotoxic-effector-cells-%C3%AE-%C3%AE-t-cells-suppress-nk-cells-but-not-ctls
#11
EDITORIAL
Dieter Kabelitz
Three types of cytotoxic effector cells can kill tumor cells: innate natural killer (NK) cells, CD8+ CTL, and γδ T cells. In this issue, Walwyn-Brown and colleagues report new insights into the interplay between these three cell types that are integral to antitumor immunity, finding that γδ T cells can specifically suppress NK cells but not CD8+ CTLs. These results are relevant in view of the so far limited efficacy of γδ T-cell immunotherapy. See related article by Walwyn-Brown et al., p. 558 (3).
May 3, 2022: Cancer Immunology Research
https://read.qxmd.com/read/34183044/gene-expression-analysis-in-ebv-infected-ataxia-telangiectasia-cell-lines-by-rna-sequencing-reveals-protein-synthesis-defect-and-immune-abnormalities
#12
JOURNAL ARTICLE
Moussab Tatfi, Emeline Perthame, Kenzo-Hugo Hillion, Marie-Agnès Dillies, Hervé Menager, Olivier Hermine, Felipe Suarez
BACKGROUND: Epstein-Barr virus (EBV) targets B-cells where it establishes a latent infection. EBV can transform B-cells in vitro and is recognized as an oncogenic virus, especially in the setting of immune compromise. Indeed, immunodeficient patients may fail to control chronic EBV infection, leading to the development EBV-driven lymphoid malignancies. Ataxia telangiectasia (AT) is a primary immune deficiency caused by mutations in the ATM gene, involved in the repair of double-strand breaks...
June 28, 2021: Orphanet Journal of Rare Diseases
https://read.qxmd.com/read/34100171/evolution-of-health-care-utilization-and-expenditure-during-the-year-before-death-in-2015-among-people-with-cancer-french-snds-based-cohort-study
#13
JOURNAL ARTICLE
Audrey Tanguy-Melac, Dorian Verboux, Laurence Pestel, Anne Fagot-Campagna, Philippe Tuppin, Christelle Gastaldi-Ménager
BACKGROUND: Cancer patients have one of the highest health care expenditures (HCE) at the end of life. However, the growth of HCE at the end of life remains poorly documented in the literature. OBJECTIVE: To describe monthly reimbursed expenditure during the last year of life among cancer patients, by performing detailed analysis according to type of expenditure and the person's age. METHOD: Data were derived from the Système national des données en santé (SNDS) [national health data system], which comprises information on ambulatory and hospital care...
September 2021: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://read.qxmd.com/read/33671606/isoforms-of-the-p53-family-and-gastric-cancer-a-m%C3%A3-nage-%C3%A3-trois-for-an-unfinished-affair
#14
REVIEW
Anais Blanchet, Agathe Bourgmayer, Jean-Emmanuel Kurtz, Georg Mellitzer, Christian Gaiddon
Gastric cancer is one of the most aggressive cancers, with a median survival of 12 months. This illustrates its complexity and the lack of therapeutic options, such as personalized therapy, because predictive markers do not exist. Thus, gastric cancer remains mostly treated with cytotoxic chemotherapies. In addition, less than 20% of patients respond to immunotherapy. TP53 mutations are particularly frequent in gastric cancer (±50% and up to 70% in metastatic) and are considered an early event in the tumorigenic process...
February 22, 2021: Cancers
https://read.qxmd.com/read/33356850/intensity-of-care-expenditure-and-place-of-death-in-french-women-in-the-year-before-their-death-from-breast-cancer-a-population-based-study
#15
JOURNAL ARTICLE
Audrey Tanguy-Melac, Pierre Denis, Anne Fagot-Campagna, Christelle Gastaldi-Ménager, Marie Laurent, Philippe Tuppin
Health care utilization of women with breast cancer (BC) during the last year of life, together with the causes and place of death and associated expenditure have been poorly described. Women treated for BC (2014-2015) with BC as a cause of death in 2015 and covered by the national health insurance general scheme (77% of the population) were identified in the French health data system (n = 6,696, mean age: 68.7 years, SD ± 15). Almost 70% died in short-stay hospitals (SSH), 4% in hospital-at-home (HaH), 9% in Rehab, 5% in skilled nursing homes (SNH) and 12% at home...
January 2020: Cancer Control: Journal of the Moffitt Cancer Center
https://read.qxmd.com/read/33272245/mnat1-promotes-proliferation-and-the-chemo-resistance-of-osteosarcoma-cell-to-cisplatin-through-regulating-pi3k-akt-mtor-pathway
#16
JOURNAL ARTICLE
Chensheng Qiu, Weiliang Su, Nana Shen, Xiaoying Qi, Xiaolin Wu, Kai Wang, Lin Li, Zhu Guo, Hao Tao, Guanrong Wang, Bohua Chen, Hongfei Xiang
BACKGROUND: MNAT1 (menage a trois 1, MAT1), a cyclin-dependent kinase-activating kinase (CAK) complex, highly expressed in diverse cancers and was involved in cancer molecular pathogenesis. However, its deliverance profile and biological function in osteosarcoma (OS) remain unclear. METHODS: The expression of MNAT1 in OS was detected by western blot (WB) and immunohistochemistry (IHC). The potential relationship between MNAT1 molecular level expression and OS clinical expectations were analyzed according to tissues microarray (TMA)...
December 3, 2020: BMC Cancer
https://read.qxmd.com/read/32756712/controlled-drug-delivery-for-cancer-cell-treatment-via-magnetic-doxorubicin-imprinted-silica-nanoparticles
#17
JOURNAL ARTICLE
Maria Nerantzaki, Aude Michel, Emmanuel Briot, Jean Michel Siaugue, Christine Ménager, Claire Wilhelm, Nébéwia Griffete
Herein, we report a facile and rapid one-step synthetic strategy for the development of magnetic doxorubicin imprinted silica nanoparticles for drug release experiments in living cells showing a remotely triggered doxorubicin release upon applying an alternating magnetic field, without temperature elevation of the medium (local heating).
August 5, 2020: Chemical Communications: Chem Comm
https://read.qxmd.com/read/32468130/tetraspanin-7-and-its-closest-paralog-tetraspanin-6-membrane-organizers-with-key-functions-in-brain-development-viral-infection-innate-immunity-diabetes-and-cancer
#18
REVIEW
Brieuc P Perot, Mickaël M Ménager
Tetraspanin (TSPAN) protein family forms a family of transmembrane proteins that act as organizers/scaffold for other proteins. TSPANs are primarily present on plasma membranes although they are also found in other biological membranes. They are organized in tetraspanin-enriched microdomains (TEMs), which allow spatiotemporal tuning of protein functions through the control of their membrane localization. TSPAN6 and TSPAN7 are close paralogs expressed in different tissues, TSPAN7 being highly expressed in the brain...
August 2020: Medical Microbiology and Immunology
https://read.qxmd.com/read/32035648/intensity-of-care-expenditure-place-and-cause-of-death-people-with-lung-cancer-in-the-year-before-their-death-a-french-population-based-study
#19
JOURNAL ARTICLE
Audrey Tanguy-Melac, Pierre Denis, Laurence Pestel, Anne Fagot-Campagna, Christelle Gastaldi-Ménager, Philippe Tuppin
INTRODUCTION: Health care utilization of people with lung cancer (LC) the last year of life, their causes of death and place of death and the associated expenditure have been poorly described together. Then we conducted an observational study. METHODS: People with LC covered by the French health Insurance general scheme (77% of the population) who died in 2015 were identified in the national health data system, together with their health care utilization and, in 95% of cases, their causes of death...
February 5, 2020: Bulletin du Cancer
https://read.qxmd.com/read/31845006/cancer-and-end-of-life-the-management-provided-during-the-year-and-the-month-preceding-death-in-2015-and-causes-of-death-in-france
#20
JOURNAL ARTICLE
Audrey Tanguy Melac, Thomas Lesuffleur, Philippe-Jean Bousquet, Anne Fagot-Campagna, Christelle Gastaldi-Ménager, Philippe Tuppin
PURPOSE: The management of cancer patients at the end of life in France and their causes of death are not well known. METHODS: People managed for cancer in 2014-2015, who died in 2015 and who were covered by the national health insurance general scheme (77% of the French population) were selected from the national health data system in order to analyze the health care reimbursed during the year and the month before their death. RESULTS: This study included 125,497 people (mean age 73 years, SD 12...
August 2020: Supportive Care in Cancer
keyword
keyword
166915
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.